Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of multiple sclerosis comprising DHODH inhibitors

Treatment of multiple sclerosis comprising DHODH inhibitors

US Patent 12433860 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vidofludimus for use in the treatment or prevention of viral diseases2024
Vidofludimus for use in the treatment or prevention of viral diseases2024
Vidofludimus for use in the treatment or prevention of viral diseases2024
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-prolifer2024
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-prolifer2024
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-prolifer2024
Treatment of multiple sclerosis comprising DHODH inhibitors2024
Treatment of multiple sclerosis comprising DHODH inhibitors2024
Treatment of multiple sclerosis comprising DHODH inhibitors2024
Compounds and dosage regimen for use in the prevention or treatment of chronic i2024
Compounds and dosage regimen for use in the prevention or treatment of chronic i2024
Compounds and dosage regimen for use in the prevention or treatment of chronic i2024